Mizuho Securities has increased its price target for Medtronic to $115, signaling strong confidence in the medical technology giant's future and a potential upside of 24.76%. The company repo...
Snowflake (NYSE: SNOW) reported strong Q2 financi...
Top Market Gainers: Small-Cap Volatility, UAE Expa...
Market Downturn: Pasqal, Credo, Palo Alto Networks ETF, FuelCell Energy, and MongoDB Lead Declines Pasqal Holding SA (NASDAQ: PSQL) declined sharply despite announcing progress in its quantum-computi
Galiano Gold Inc. (NYSE: GAU) demonstrates exceptional capital efficiency within the gold mining sector. Its Return on Invested Capital (ROIC) of 24.38% significantly exceeds its Weighted Ave
PHINIA (NYSE:PHIN) Director, President, and CEO Ericson Brady D recently sold 27,860 shares in two transactions, adjusting his total holdings to 330,497 shares. The automotive industry suppli
Rezolve AI (NASDAQ: RZLV) Price Target Cut Despite Rapid Revenue Growth Rezolve AI reported $130.8 million in H1 2026 revenue, up approximately 1,970% from $6.3 million a year earlier. Roth Capital r
H.C. Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ: HALO) Amid Strong Financial Performance Analyst firm H.C. Wainwright reaffirmed its Buy rating for Halozyme Therapeutics (NASDA
Sprinklr (NYSE: CXM) exceeded analyst expectations for earnings per share in Q2 2027, demonstrating consistent profitability. Despite a slight revenue miss, the customer experience software p
